CERS vs USB · rev $201.3M vs P/E 12, rev $28.66B
Cerus Corporation (CERS) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
CERS currently screens at market cap $294.4M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the CERS and USB stock pages for the full models.
Not investment advice.